Flipkart

News Summary:

On July 10, 2026, Flipkart, alongside other e-commerce platforms, saw a proliferation of misleading weight-loss products marketed under the GLP-1 drug's name despite having no relation to the drug, amid India's surging demand for GLP-1 weight-loss medications. Earlier that day, Flipkart reported a 50% year-on-year growth in its food and nutrition category, attributing the increase significantly to Gen Z consumers and shoppers from Tier 2 and smaller markets, with Flipkart Minutes accounting for 25% of the category's demand. This growth reflects a structural shift in India's online food and nutrition market, evolving into a discovery-led business driven by premiumisation, health consciousness, and consumers from "Bharat," making it one of the company's fastest-growing FMCG verticals. Also on July 10, the All-India Consumer Products Distributors Federation (AICPDF) called for immediate government intervention regarding the proposed expansion of e-commerce giants, including Flipkart, into India's quick commerce sector, raising serious concerns about compliance with the nation's Foreign Direct Investment (FDI) rules. Additionally, the NCLT Bengaluru dismissed a petition filed by Netambit Value First Services Private Limited against Flipkart Internet Private Limited under Section 9 of the Insolvency and Bankruptcy Code 2016 (IBC) to initiate a Corporate Insolvency Resolution Process (CIRP) for an alleged operational debt, citing a pre-existing dispute on service performance.